Aethon
www.aethon.com
Aethon designs and manufactures courier robots for hospitals for tracking and recovering goods,
finding and delivering goods, depending on the hospital's specialized needs.
|
|
|
Biodel, Inc.
www.biodel.com
Biodel Inc. is a biopharmaceutical drug delivery companythat has developed a novel drug formulation of
recombinant human insulin designed to speed the delivery of insulin into the blood called
ViajectTM to treat patients with Type 1 and Type 2 diabetes.
|
|
|
Cequent Pharmaceuticals, Inc.
www.cequentpharma.com
Cequent has developed a novel therapeutic probiotic designed to deliver inhibitory RNA directly to the gut for
the treatment of a variety of gastrointestinal disorders such as irritable bowel disease, Crohn's disease, familial
polyposis (pre-colon cancer) and colon cancer. In 2010, the Company merged with NASDAQ-listed MDRNA. The newly
combined companies were renamed Marina Biotech Inc.
|
|
|
Cutanea Life Sciences, Inc.
www.cutanealife.com
Cutanea Life Sciences is a development stage specialty pharmaceutical company whose mission
is to strategically in-license novel, mid-stage candidates to treat diseased and aging skin conditions.
|
|
|
Deltex Medical
www.deltexmedical.com (EASDAQ: DLTX)
Deltex, based in Chichester, England and Greenville, SC, develops, manufactures, and markets minimally invasive
cardiac output monitoring devices. To date, the Company has developed three products, one of which is already
being sold in Europe, North America (FDA approved) and Asia. The marketed product is a non-invasive cardiac
function monitor, which uses Doppler ultrasound technology.
|
|
|
EffRx, Inc.
www.effrx.com
EffRx, based in Switzerland, has developed and patented an improved effervescent technology that covers
most pharmaceutical compounds of commercial significance. The Company has an exclusive worldwide license
from Merck & Co to an effervescent form of FOSAMAX.
|
|
|
Energetiq Technology, Inc.
www.energetiq.com
Energetiq develops and manufactures short wavelength light sources for use in the analysis and fabrication
of nano-scale structures and products to enable the production of next generation devices to be used in
lithography, metrology, inspection, thin-film processing, soft X-Ray Microscopy and a variety of applications
including research instruments.
|
|
|
EyeGate Pharmaceuticals, Inc.
www.eyegatepharma.com
EyeGate Pharmaceuticals is developing a proprietary platform of medicines to treat diseases of the eye using its unique,
non-invasive, iontopheretic drug-delivery system called EyeGate® II.
|
|
|
Kiyatec
www.kiyatec.com
Kiyatec is commercializing novel 3D cell culture
technology, developed at Clemson University, and is providing tools for researchers and clinicians with
advanced in vitro models for improved understanding in cell and systems biology, drug development, and clinical diagnosis.
|
|
|
Lab 21 Limited
www.lab21.com
Lab21, based in Cambridge, England and Greenville, SC, provides diagnostic products and services to blood
bank screening, medical diagnostics and drug discovery partners. The Company has grown through a combination
of strong organic growth and acquisition.
|
|
|
Magellan Biosciences, Inc.
www.magellanbio.com
Magellan serves the worldwide clinical-diagnostics market with rapid point-of-care analyzers and automated systems
for near-patient testing. Magellan serves customers through wholly owned subsidiaries with brands that include
LeadCare, TREK and Dynex.
|
|
|
Mini-Lap Technologies, Inc.
www.mini-lap.com
Minilap is developing and marketing ultra minimally invasive surgical instruments with direct-through-skin capability,
eliminating the need to close the puncture and leaving little or no residual scar. The Company has entered into a
world-wide license with Stryker.
|
|
|
mtm Laboratories, AG
www.mtm-laboratories.com
mtm laboratories, based in Heidelberg, Germany and Westborough, Massachusetts, is a certified developer and manufacturer of
In-vitro Diagnostics for screening and diagnosis of cervical cancer with products marketed worldwide.
|
|
|
Myconostica, Ltd.
www.myconostica.co.uk
Myconostica, a Manchester, England and Charleston, SC based company, has developed assays that represent a novel application of
molecular diagnostics to the area of infectious fungal disease. The first product will provide an assay to detect infectious
fungi of the respiratory tract and will provide a diagnosis within hours.
|
|
|
MyoScience, Inc.
www.myoscience.com
MyoScience, Inc. is developing a patented, device-based approach to treating dynamic wrinkles.
|
|
|
Neurotech, Inc.
www.neurotechusa.com
Neurotech, located in Rhode Island, is developing a proprietary delivery technology focused on sight-saving
therapeutics for chronic retinal diseases. Neurotech's lead product is in clinical development for the treatment
of retinal degeneration, including retinitis pigmentosa, an inherited disease leading to blindness, and macular degeneration.
|
|
|
NuvoLase
www.nuvolase.com
NuvoLase acquired all of the assets of PathoLase, including the PinPointe Laser, and is successfully marketing the first laser technology with clinically proven efficacy and FDA clearance for the treatment of onychomycosis.
|
|
|
Presidio Pharmaceuticals, Inc.
www.presidiopharma.com
Presidio Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on development and
commercialization of novel small molecule antiviral therapeutics, initially for the treatment of hepatitis B.
|
|
|
Sabal Medical, Inc.
www.sabalmedical.com
Sabal Medical, Inc. is a Charleston, SC-based developer and manufacturer of proprietary medication safety solutions.
The Sabal Solution replaces traditional medication cabinets, mobile medication carts and stand-alone point of care software.
Sabal was sold in early 2011 to Swisslog, an internationally-known logistics company with sales to hospitals all over the world.
|
|
|
Selah Genomics, Inc.
www.SelahGenomics.com
Selah Genomics is a clinical diagnostic company that is rapidly growing at the cutting edge of molecular analysis and next generation sequencing (NGS), and is emerging as a leader in the development of personalized medicine.
|
|
|
Spectra Analysis Instruments, Inc.
www.spectra-analysis.com
Spectra Analysis is a molecular spectroscopy and optical detection platform technology company.
The company is a leading supplier of molecular spectroscopy systems and applications for chromatography
used in drug discovery and forensic applications.
|
|
|
Sultan Scientific, Ltd.
Sultan has built a portfolio of company shareholdings in both the healthcare and environmental sectors.
Operating internationally, the Group identifies niche markets, aggregates compelling new technologies,
attracts experienced management then invests in commercial validation and extension of robust intellectual
property assets in order to build specialized companies.
|
|
|
Vital Sensors
www.vitalsensors.com
Vital Sensors, based in Hannover, Germany with plans to open a US headquarters in South Carolina,
is developing surgically-implanted, chip-based pressure sensors. Telemetric measurement of pressure has the
potential of transforming the management of heart failure by allowing physicians to monitor intra-cardiac
hemodynamic pressure to guide drug and other therapies.
|
|
|
Zipit Wireless, Inc.
www.zipitwireless.com
Zipit, based in Greenville, SC, develops and licenses
device software and operates network services for
communications, consumer electronics, and enterprise
technology companies that want to enable, connect,
and manage wireless devices. Verizon Wireless is
partnering with Zipit Wireless to launch a new two-way
paging system for healthcare professionals.
|
|
